Unlocking Strategic Value in Drug Safety for Life Sciences Organizations
This webinar aims to explore the transformation of safety teams from reactive cost centers to proactive benefit drivers, emphasizing the importance of providing teams with the right tools & resources to gain actionable insights.
hts.
Watch the webinar on demand
What you'll learn
- Regulatory compliance and updates
- Technology integration for pharmacovigilance
- Global collaboration in safety monitoring
- Patient-centric approaches to Pharmacovigilance through digital health technologies
- Leveraging real-world data for enhanced drug safety
Learn from the best
Speakers
Join us as our expert speakers share valuable insights and practical knowledge drawn from extensive industry experience.
Dr. Ángel Navarro
Country Manager Spain & Head of Global Vigilance Division
Dr. Angel Navarro is the Country Manager of Spain of QbD Group and Head of Vigilance Division. Founder and CEO of Azierta for more than 12 years (Azierta part of QbD Group), his track record endorses him as a strategic leader in the international pharmaceutical sector.
Dr. Antonio Borregón
Head Global Business Development Pharma
Dr. Antonio Borregón is the Global Business Development Pharma Head at QbD Group. He has extensive experience in the pharmaceutical field with high-responsibility positions at the international level.
Dr. Richard Habis
Richard Habis, a PharmD graduate from Saint Joseph University of Beirut, is a **seasoned expert in biopharmaceutical consulting and market research.** With a keen focus on rare diseases and patient-centered care, his expertise extends to leveraging real-world data to drive patient outcomes and healthcare insights. Mr. Habis’s professional journey reflects a strong commitment to integrating patient perspectives in digital health solutions.